RECURSION PHARMACEUTICALS IN shareholders Q3 2023

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 190 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.9%.

RECURSION PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
GoalFusion Wealth Management, LLC 20,000$153,0000.11%
AXQ CAPITAL, LP 29,000$221,8500.08%
Bridgefront Capital, LLC 14,490$110,8490.08%
PROFUND ADVISORS LLC 184,235$1,409,3980.08%
Jump Financial, LLC 253,464$1,939,0000.07%
Liontrust Investment Partners LLP 520,000$3,978,1630.06%
New World Advisors LLC 22,725$173,8460.06%
TITLEIST ASSET MANAGEMENT, LLC 35,750$273,4880.06%
Tri Locum Partners LP 22,471$171,9030.06%
Bayesian Capital Management, LP 59,611$456,0240.05%
Rafferty Asset Management, LLC 1,104,526$8,449,6240.05%
Virtus ETF Advisers LLC 10,032$76,7450.05%
Laurion Capital Management LP 907,616$6,943,2620.04%
E Fund Management Co., Ltd. 56,732$4340.03%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 854,395$6,536,1220.03%
Sumitomo Mitsui Trust Holdings, Inc. 3,523,124$26,951,8990.02%
Bellevue Group AG 174,085$1,331,7500.02%
PRELUDE CAPITAL MANAGEMENT, LLC 42,959$328,6360.02%
Clarius Group, LLC 28,601$218,7980.02%
Resolute Advisors LLC 14,670$112,2260.02%
External links

This page lists RECURSION PHARMACEUTICALS IN's shareholders in Q3 2023. To view RECURSION PHARMACEUTICALS IN's shareholder history, click here.